French study tracks Real-World breast cancer treatment patterns

NCT ID NCT06856343

Recruiting now Knowledge-focused Sponsor: AstraZeneca Source: ClinicalTrials.gov ↗

Summary

This French study observes breast cancer patients taking a medication called olaparib for 12 months in real-world settings. Researchers want to see how many patients complete the full treatment course and understand factors that might affect completion. The study collects information about patients' genetic characteristics and medical history to better understand treatment patterns.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Research Site
NOT_YET_RECRUITING

Agen, France
Research Site
NOT_YET_RECRUITING

Argenteuil, France
Research Site
NOT_YET_RECRUITING

Avignon, France
Research Site
NOT_YET_RECRUITING

Beauvais, France
Research Site
NOT_YET_RECRUITING

Beuvry, France
Research Site
NOT_YET_RECRUITING

Bezannes, France
Research Site
NOT_YET_RECRUITING

Caen, France
Research Site
RECRUITING

Chambray-lès-Tours, France
Research Site
NOT_YET_RECRUITING

Champigny-sur-Marne, France
Research Site
RECRUITING

Clermont-Ferrand, France
Research Site
NOT_YET_RECRUITING

Compiègne, France
Research Site
NOT_YET_RECRUITING

Creil, France
Research Site
NOT_YET_RECRUITING

Dechy, France
Research Site
NOT_YET_RECRUITING

FORT de France Cedex, France
Research Site
NOT_YET_RECRUITING

Fréjus, France
Research Site
RECRUITING

Gleizé, France
Research Site
NOT_YET_RECRUITING

Grenoble, France
Research Site
NOT_YET_RECRUITING

Le Blanc-Mesnil, France
Research Site
NOT_YET_RECRUITING

Lille, France
Research Site
NOT_YET_RECRUITING

Limoges, France
Research Site
NOT_YET_RECRUITING

Lyon, France
Research Site
NOT_YET_RECRUITING

Marseille, France
Research Site
RECRUITING

Metz-Tessy, France
Research Site
NOT_YET_RECRUITING

Montpellier, France
Research Site
RECRUITING

Montpellier, France
Research Site
RECRUITING

Nancy, France
Research Site
NOT_YET_RECRUITING

Nice, France
Research Site
NOT_YET_RECRUITING

Osny, France
Research Site
NOT_YET_RECRUITING

Paris, France
Research Site
NOT_YET_RECRUITING

Périgueux, France
Research Site
NOT_YET_RECRUITING

Plérin, France
Research Site
NOT_YET_RECRUITING

Poitiers, France
Research Site
RECRUITING

Rouen, France
Research Site
NOT_YET_RECRUITING

Saint-Brieuc, France
Research Site
NOT_YET_RECRUITING

Saint-Doulchard, France
Research Site
NOT_YET_RECRUITING

Saint-Etienne, France
Research Site
RECRUITING

Saint-Grégoire, France
Research Site
NOT_YET_RECRUITING

Saint-Martin-Boulogne, France
Research Site
NOT_YET_RECRUITING

Saint-Pierre-des-Corps, France
Research Site
NOT_YET_RECRUITING

Saint-Priest-en-Jarez, France
Research Site
NOT_YET_RECRUITING

Salouël, France
Research Site
NOT_YET_RECRUITING

Thonon-les-Bains, France
Research Site
NOT_YET_RECRUITING

Valence, France
Research Site
RECRUITING

Valence, France

Conditions

Explore the condition pages connected to this study.

BREAST CANCER